JP2013544276A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544276A5
JP2013544276A5 JP2013541445A JP2013541445A JP2013544276A5 JP 2013544276 A5 JP2013544276 A5 JP 2013544276A5 JP 2013541445 A JP2013541445 A JP 2013541445A JP 2013541445 A JP2013541445 A JP 2013541445A JP 2013544276 A5 JP2013544276 A5 JP 2013544276A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
optionally substituted
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013541445A
Other languages
English (en)
Japanese (ja)
Other versions
JP5777725B2 (ja
JP2013544276A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/055104 external-priority patent/WO2012073138A1/en
Publication of JP2013544276A publication Critical patent/JP2013544276A/ja
Publication of JP2013544276A5 publication Critical patent/JP2013544276A5/ja
Application granted granted Critical
Publication of JP5777725B2 publication Critical patent/JP5777725B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013541445A 2010-11-29 2011-11-15 モノバクタム Expired - Fee Related JP5777725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41757510P 2010-11-29 2010-11-29
US61/417,575 2010-11-29
PCT/IB2011/055104 WO2012073138A1 (en) 2010-11-29 2011-11-15 Monobactams

Publications (3)

Publication Number Publication Date
JP2013544276A JP2013544276A (ja) 2013-12-12
JP2013544276A5 true JP2013544276A5 (cg-RX-API-DMAC10.html) 2014-12-04
JP5777725B2 JP5777725B2 (ja) 2015-09-09

Family

ID=45315854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013541445A Expired - Fee Related JP5777725B2 (ja) 2010-11-29 2011-11-15 モノバクタム

Country Status (17)

Country Link
US (3) US20120302542A1 (cg-RX-API-DMAC10.html)
EP (1) EP2646436B1 (cg-RX-API-DMAC10.html)
JP (1) JP5777725B2 (cg-RX-API-DMAC10.html)
KR (1) KR101514587B1 (cg-RX-API-DMAC10.html)
CN (1) CN103228652B (cg-RX-API-DMAC10.html)
AR (1) AR084001A1 (cg-RX-API-DMAC10.html)
AU (1) AU2011336209B2 (cg-RX-API-DMAC10.html)
CA (1) CA2815821C (cg-RX-API-DMAC10.html)
DK (1) DK2646436T3 (cg-RX-API-DMAC10.html)
ES (1) ES2542431T3 (cg-RX-API-DMAC10.html)
IL (1) IL226052A0 (cg-RX-API-DMAC10.html)
MX (1) MX2013005994A (cg-RX-API-DMAC10.html)
SG (1) SG190007A1 (cg-RX-API-DMAC10.html)
TW (1) TW201247661A (cg-RX-API-DMAC10.html)
UY (1) UY33754A (cg-RX-API-DMAC10.html)
WO (1) WO2012073138A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201304479B (cg-RX-API-DMAC10.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015099107A1 (ja) 2013-12-26 2015-07-02 塩野義製薬株式会社 含窒素6員環誘導体およびそれらを含有する医薬組成物
TWI714525B (zh) 2014-03-24 2021-01-01 瑞士商諾華公司 用於治療細菌感染之單內醯胺(monobactam)有機化合物
CN108137573B (zh) 2015-09-23 2021-06-11 诺华股份有限公司 单环内酰胺抗生素的盐和固体形式
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
EP3390357B1 (en) 2015-12-15 2021-11-10 Merck Sharp & Dohme Corp. Biaryl monobactam compounds for the treatment of bacterial infections
US10407421B2 (en) 2016-03-07 2019-09-10 Merck Sharp & Dohme Corp Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
WO2017180794A1 (en) 2016-04-13 2017-10-19 Skyline Antiinfectives, Inc. Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
CN107641119B (zh) 2016-07-21 2019-11-08 中国科学院上海药物研究所 单环β-内酰胺-铁载体轭合物及其制备方法和用途
EP3661933B1 (en) 2017-08-02 2022-03-23 Novartis AG Process for preparing 1-(((z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3s,4r)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid
WO2019070492A1 (en) 2017-10-02 2019-04-11 Merck Sharp & Dohme Corp. CHROMANE MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
US10513504B2 (en) 2018-03-08 2019-12-24 Apotex Inc. Processes for the preparation of apalutamide and intermediates thereof
KR102786898B1 (ko) * 2019-11-22 2025-03-25 쑤저우 얼예 파마슈티칼 컴퍼니 리미티드 설포닐우레아 고리 치환 모노시클릭 β-락탐계 항생제
AU2020397059A1 (en) 2019-12-06 2022-07-21 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
CN111303144B (zh) * 2019-12-13 2020-11-27 苏州信诺维医药科技有限公司 一种治疗细菌感染的化合物
US12528804B2 (en) 2021-03-31 2026-01-20 Fedora Pharmaceuticals Inc. Lactivicin compounds, their preparation and use as antibacterial agents
KR20230163532A (ko) 2021-03-31 2023-11-30 페도라 파마슈티칼스 인코포레이티드 락티비신 화합물, 이의 제조 및 항균제로서의 용도
WO2022235077A1 (ko) * 2021-05-07 2022-11-10 한국생명공학연구원 신규 사이드로포어 화합물 및 이를 이용한 금속 나노입자 복합체
CN117794920A (zh) 2021-06-04 2024-03-29 沃泰克斯药物股份有限公司 N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
GEAP202416514A (en) 2021-11-18 2024-08-26 Merck Sharp & Dohme Llc Chromane amidine monobactam antibiotics
JP7671398B2 (ja) * 2021-11-18 2025-05-01 メルク・シャープ・アンド・ドーム・エルエルシー クロマンアミジンモノバクタム抗生物質
EP4511116A1 (en) 2022-04-22 2025-02-26 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
CN115304594B (zh) * 2022-10-12 2023-02-14 苏州二叶制药有限公司 磺酰脲环取代的化合物的盐型及其晶型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7541487A (en) * 1986-05-23 1987-12-22 Upjohn Company, The N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
EP2308874B1 (en) 2005-12-07 2013-01-23 Basilea Pharmaceutica AG Bridged monobactams useful as beta-lactamase inhibitors
CN102964296B (zh) 2007-03-28 2015-03-25 阿普泰克斯科技公司 去铁酮的氟化衍生物
JP2012512863A (ja) 2008-12-19 2012-06-07 ファイザー・インク モノカルバム

Similar Documents

Publication Publication Date Title
JP2013544276A5 (cg-RX-API-DMAC10.html)
JP2012502974A5 (cg-RX-API-DMAC10.html)
JP2008531599A5 (cg-RX-API-DMAC10.html)
JP2013510120A5 (cg-RX-API-DMAC10.html)
JP2013507434A5 (cg-RX-API-DMAC10.html)
JP2006524660A5 (cg-RX-API-DMAC10.html)
JP2013514980A5 (cg-RX-API-DMAC10.html)
JP2019513778A5 (cg-RX-API-DMAC10.html)
JP2009535358A5 (cg-RX-API-DMAC10.html)
JP2014530900A5 (cg-RX-API-DMAC10.html)
JP2013505969A5 (cg-RX-API-DMAC10.html)
JP2015512931A5 (cg-RX-API-DMAC10.html)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2012512863A5 (cg-RX-API-DMAC10.html)
JP2005523922A5 (cg-RX-API-DMAC10.html)
JP2013544860A5 (cg-RX-API-DMAC10.html)
HRP20170352T1 (hr) Spojevi bis(fluroalkil)-1,4-benzodiazepinona kao notch inhibitori
AR084001A1 (es) Monobactamas y su uso en el tratamiento de infecciones bacterianas
JP2014528464A5 (cg-RX-API-DMAC10.html)
JP2014500265A5 (cg-RX-API-DMAC10.html)
JP2013525286A5 (cg-RX-API-DMAC10.html)
JP2010132677A5 (cg-RX-API-DMAC10.html)
JP2015514063A5 (cg-RX-API-DMAC10.html)
JP2008534453A5 (cg-RX-API-DMAC10.html)
JP2016503403A5 (cg-RX-API-DMAC10.html)